Exscientia Ltd Adr Stock Return On Equity
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Exscientia's long-term financial health and intrinsic value.
Exscientia |
Exscientia Ltd ADR Company Return On Equity Analysis
Exscientia's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Exscientia Return On Equity | -0.46 |
Most of Exscientia's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Exscientia Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Exscientia Ltd ADR has a Return On Equity of -0.4643. This is 98.06% lower than that of the Biotechnology sector and 98.73% lower than that of the Health Care industry. The return on equity for all United States stocks is 49.77% higher than that of the company.
Exscientia Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Exscientia's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics of similar companies.Exscientia is currently under evaluation in return on equity category among its peers.
Exscientia Fundamentals
| Return On Equity | -0.46 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (10.66) % | |||
| Current Valuation | 346.92 M | |||
| Shares Outstanding | 130.82 M | |||
| Shares Owned By Insiders | 25.90 % | |||
| Shares Owned By Institutions | 20.80 % | |||
| Number Of Shares Shorted | 2.81 M | |||
| Price To Book | 1.95 X | |||
| Price To Sales | 37.10 X | |||
| Revenue | 20.08 M | |||
| Gross Profit | 10.25 M | |||
| EBITDA | (145.45 M) | |||
| Net Income | (145.96 M) | |||
| Cash And Equivalents | 601.89 M | |||
| Cash Per Share | 4.91 X | |||
| Total Debt | 18.92 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 9.08 X | |||
| Book Value Per Share | 1.95 X | |||
| Cash Flow From Operations | (117.6 M) | |||
| Short Ratio | 5.77 X | |||
| Earnings Per Share | (1.51) X | |||
| Price To Earnings To Growth | 0.10 X | |||
| Target Price | 4.35 | |||
| Number Of Employees | 483 | |||
| Beta | 0.84 | |||
| Market Capitalization | 633.18 M | |||
| Total Asset | 510.72 M | |||
| Retained Earnings | (110.47 M) | |||
| Working Capital | 339.87 M | |||
| Net Asset | 510.72 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |